EMA Thumbs Up For HyQvia As Maintenance Therapy For Rare Neurological Disorder

The European Medicines Agency has recommended in favor of allowing new uses of four already-approved drugs and suspending the marketing authorization of several generics tested by an Indian-based CRO.